Total Payments
$4,294
2024 Payments
$455.61
Companies
24
Transactions
233
Medicare Patients
8,258
Medicare Billing
$829,811
Payment Breakdown by Category
Food & Beverage$4,114 (95.8%)
Education$179.94 (4.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,114 | 231 | 95.8% |
| Education | $179.94 | 2 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $926.23 | 71 | $0 (2023) |
| ATRICURE, INC. | $491.25 | 14 | $0 (2024) |
| Amgen Inc. | $487.49 | 34 | $0 (2023) |
| PFIZER INC. | $329.34 | 26 | $0 (2023) |
| Abbott Laboratories | $302.58 | 4 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $237.10 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $204.46 | 15 | $0 (2023) |
| Astellas Pharma US Inc | $193.50 | 3 | $0 (2018) |
| Philips Electronics North America Corporation | $190.41 | 24 | $0 (2023) |
| Lantheus Medical Imaging, Inc. | $169.61 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $455.61 | 19 | ATRICURE, INC. ($174.36) |
| 2023 | $722.56 | 31 | ATRICURE, INC. ($257.29) |
| 2022 | $588.34 | 50 | Janssen Pharmaceuticals, Inc ($188.12) |
| 2021 | $189.78 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($116.45) |
| 2020 | $294.27 | 15 | Janssen Pharmaceuticals, Inc ($162.50) |
| 2019 | $830.28 | 68 | Janssen Pharmaceuticals, Inc ($315.63) |
| 2018 | $687.55 | 31 | Amgen Inc. ($222.24) |
| 2017 | $525.33 | 13 | Abbott Laboratories ($170.74) |
All Payment Transactions
233 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $14.58 | General |
| Category: Medical Device | ||||||
| 12/09/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $15.63 | General |
| Category: Medical Device | ||||||
| 10/31/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $16.37 | General |
| Category: Medical Device | ||||||
| 10/24/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: CDS - BG Mini_RM | ||||||
| 10/07/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $1.92 | General |
| Category: Medical Device | ||||||
| 08/31/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $1.00 | General |
| Category: Medical Device | ||||||
| 07/31/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $17.46 | General |
| Category: Medical Device | ||||||
| 07/26/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $7.20 | General |
| Category: Medical Device | ||||||
| 07/23/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $40.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/19/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $15.20 | General |
| Category: Medical Device | ||||||
| 06/05/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $121.55 | General |
| Category: Genetic Disease | ||||||
| 05/09/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/07/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $41.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/02/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $16.20 | General |
| Category: Medical Device | ||||||
| 04/30/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/15/2024 | Philips North America LLC | (5050) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $15.89 | General |
| Category: Medical Device | ||||||
| 03/06/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $6.11 | General |
| Category: Medical Device | ||||||
| 01/31/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $18.17 | General |
| Category: Medical Device | ||||||
| 12/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $3.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/01/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $16.54 | General |
| Category: Medical Device | ||||||
| 11/30/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $15.60 | General |
| Category: Medical Device | ||||||
| 11/28/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $39.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/27/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $112.76 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,638 | 2,116 | $751,242 | $163,874 |
| 2022 | 21 | 1,926 | 2,643 | $874,936 | $202,852 |
| 2021 | 21 | 2,380 | 3,199 | $970,035 | $235,505 |
| 2020 | 20 | 2,314 | 3,098 | $904,794 | $227,580 |
Total Patients
8,258
Total Services
11,056
Medicare Billing
$829,811
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 109 | 109 | $166,116 | $41,302 | 24.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 173 | 174 | $155,754 | $27,538 | 17.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 146 | 214 | $85,600 | $20,403 | 23.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 81 | 136 | $61,200 | $18,715 | 30.6% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 112 | 116 | $70,560 | $13,842 | 19.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 72 | 270 | $34,020 | $12,102 | 35.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 158 | 160 | $62,914 | $9,169 | 14.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 116 | 116 | $35,032 | $6,332 | 18.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 178 | 308 | $25,564 | $3,508 | 13.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $13,240 | $3,272 | 24.7% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 114 | 117 | $8,775 | $2,285 | 26.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 183 | 197 | $7,880 | $1,234 | 15.7% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 34 | 34 | $4,930 | $1,216 | 24.7% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 77 | 79 | $12,324 | $1,199 | 9.7% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 34 | 35 | $4,760 | $1,107 | 23.3% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 31 | 31 | $2,573 | $651.00 | 25.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 120 | 120 | $182,880 | $50,010 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 164 | 283 | $116,736 | $28,049 | 24.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 144 | 144 | $129,148 | $25,023 | 19.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 84 | 143 | $62,259 | $21,360 | 34.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 100 | 397 | $50,022 | $19,255 | 38.5% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 128 | 128 | $78,750 | $15,869 | 20.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 265 | 276 | $108,154 | $15,650 | 14.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 139 | 139 | $41,978 | $7,695 | 18.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 202 | 406 | $33,698 | $4,771 | 14.2% |
About Dr. Ri Cha, MD
Dr. Ri Cha, MD is a Cardiovascular Disease healthcare provider based in Camden, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164502878.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ri Cha, MD has received a total of $4,294 in payments from pharmaceutical and medical device companies, with $455.61 received in 2024. These payments were reported across 233 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,114).
As a Medicare-enrolled provider, Cha has provided services to 8,258 Medicare beneficiaries, totaling 11,056 services with total Medicare billing of $829,811. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Camden, NJ
- Active Since 10/17/2006
- Last Updated 05/20/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1164502878
Products in Payments
- XARELTO (Drug) $926.23
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $491.25
- Corlanor (Drug) $434.34
- (5044) MCOT (Device) $261.07
- JARDIANCE (Drug) $237.10
- VYNDAQEL (Drug) $217.69
- ENTRESTO (Drug) $172.60
- Definity (Drug) $169.61
- Occluders (Device) $141.22
- CAMZYOS (Drug) $134.35
- Accent Pacemaker (Device) $131.84
- AMVUTTRA (Drug) $121.55
- Adempas (Drug) $101.82
- ELIQUIS (Drug) $72.83
- CHANTIX (Drug) $53.18
- Repatha (Biological) $53.15
- LifeVest (Device) $48.21
- (5050) Ext Holter (Device) $43.04
- KENGREAL (Drug) $32.84
- (5050) Extended Holter (Device) $32.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Camden
Dr. Perry Weinstock, M.d, M.D
Cardiovascular Disease — Payments: $257,830
Cardiovascular Disease $257,830
Mubashar Khan, M.d, M.D
Cardiovascular Disease — Payments: $33,373
Cardiovascular Disease $33,373
Zoltan Turi, Md, MD
Cardiovascular Disease — Payments: $28,055
Cardiovascular Disease $28,055
Dr. Devinder Singh, M.d, M.D
Cardiovascular Disease — Payments: $21,241
Cardiovascular Disease $21,241
Dr. Brian Corbett, D.o, D.O
Cardiovascular Disease — Payments: $16,931
Cardiovascular Disease $16,931
Kathleen Heintz, Do, DO
Cardiovascular Disease — Payments: $10,143
Cardiovascular Disease $10,143